Skip to content

Pharmacokinetic Alteration of Pethidine in Patients Following Lower-Limb Orthopedic Surgery.

Pharmacokinetic Alteration of Pethidine in Patients Following Lower-Limb Orthopedic Surgery and its Relationship with the Intensity of Pain in these Patients.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201508093106N28
Enrollment
12
Registered
2015-12-24
Start date
2015-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of Lower Limb. Fracture of lower limb, level unspecified

Interventions

After the surgery and following transference of the patients to the recovery section, 25 mg pethidine was injected intravenously..
Treatment - Drugs
After the surgery and following transference of the patients to the recovery section, 25 mg pethidine was injected intravenously.

Sponsors

Vice Chancellor for Research Affairs, Islamic Azad University, Pharmaceutical Sciences Branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria include: Age between 18 and 35 years; Not having substance abuse; Having physical and mental health; Having post-operative pain; Having full consciousness; Being classified as class I patients (according to the American society of anesthesiologists physical status classification). Exclusion Criteria include: Pregnancy; Lactation; Having seizures; Having psychiatric disorders; Undergoing emergency surgical operations; Having abnormal paraclinical tests.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Assessment of pain intensity. Timepoint: 5, 30, 60 and 180 minutes after drug injection. Method of measurement: Based on Visual Analogue Scale (VAS).;Measuring blood levels of pethidine. Timepoint: 5, 30, 60 and 180 minutes after injection. Method of measurement: with HPLC Method.

Secondary

MeasureTime frame
Adverse drug reactions. Timepoint: 5, 30, 60 and 180 minutes after injection of the drug. Method of measurement: Observation and clinical studies.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farshad Hashemian

Islamic Azad University, Pharmaceutical Sciences Branch, Faculty of Pharmacy

hashemian.f@iaups.ac.ir+98 21 2264 0056

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026